350 related articles for article (PubMed ID: 17154104)
1. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
Tanaka Y
Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
[TBL] [Abstract][Full Text] [Related]
2. [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
Tanaka Y
Clin Calcium; 2010 May; 20(5):735-42. PubMed ID: 20445285
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress of pathogenesis and treatments in rheumatoid arthritis].
Tanaka Y
Clin Calcium; 2005 Jul; 15(7):23-8. PubMed ID: 15995292
[TBL] [Abstract][Full Text] [Related]
4. [Pathologic condition of osteoporosis in rheumatoid arthritis].
Suwa A; Saito E; Wakabayashi T; Suzuki Y
Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin-1 in bone resorption in rheumatoid arthritis.
Strand V; Kavanaugh AF
Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
7. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
Tanaka Y
Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].
Tanaka Y
Clin Calcium; 2010 Oct; 20(10):1545-52. PubMed ID: 20890038
[TBL] [Abstract][Full Text] [Related]
9. [Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].
Soen S
Clin Calcium; 2008 Aug; 18(8):1169-75. PubMed ID: 18677056
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory cytokines for osteoclastogenesis].
Tanaka Y
Nihon Rinsho; 2005 Sep; 63(9):1535-40. PubMed ID: 16164208
[TBL] [Abstract][Full Text] [Related]
11. [Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis].
Tanaka Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2377-9. PubMed ID: 19149029
[No Abstract] [Full Text] [Related]
12. A new era in rheumatoid arthritis treatment.
Costello JC; Halverson PB
WMJ; 2003; 102(7):29-33. PubMed ID: 14711021
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
Güler-Yüksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Hulsmans HM; de Beus WM; Han KH; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF
Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic agents for rheumatoid arthritis: infliximab (a chimeric human IgG 1 monoclonal antibody to TNF-alpha) and etanercept (a soluble form of human TNF type II receptor linked to an IgG 1-Fc moietry)].
Akiyama Y; Mimura T
Masui; 2006 Jul; 55(7):864-72. PubMed ID: 16856547
[TBL] [Abstract][Full Text] [Related]
17. [Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
Suzuki Y
Clin Calcium; 2007 Dec; 17(12):1909-13. PubMed ID: 18057668
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
Okada Y; Nawata M; Tanaka Y
Clin Calcium; 2009 Aug; 19(8):1186-90. PubMed ID: 19638703
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of the joint destruction in RA by TNF-blocking agents].
Kameda H
Clin Calcium; 2007 Apr; 17(4):553-60. PubMed ID: 17404485
[TBL] [Abstract][Full Text] [Related]
20. [Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein].
Fujikawa K; Kawakami A; Eguchi K
Nihon Rinsho; 2007 Jul; 65(7):1211-7. PubMed ID: 17642234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
